US2022195394A1PendingUtilityA1
Three-dimensional printed organs, devices, and matrices
Est. expiryMay 25, 2037(~10.8 yrs left)· nominal 20-yr term from priority
C07K 16/116C12N 5/064C12N 5/0638C12N 5/0637C12N 5/0635C12N 5/0669C12N 2527/00C12N 5/0697C12N 2533/74C12N 2506/1384C12N 2502/1323C12M 3/04C12N 2502/094C12N 2513/00C12N 5/0062C12N 5/0698C07K 2317/21C07K 2317/76C12N 2502/1121C12N 2533/76C12N 5/0671C12N 2502/45C12N 2502/09C12N 2506/28C12N 2533/30C12N 2510/02C12N 5/0691C12N 2502/1114C12N 2539/10C12N 2533/54C12N 5/0667C12N 5/0018C12N 2533/80C07K 16/00C07K 16/1081
66
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Provided herein are methods and systems for bio-printing of three-dimensional organs and organoids. Also provided herein are bio-printed three-dimensional organs and organoids for use in the generation and/or the assessment of immunological products and/or immune responses. Also provided herein are methods and system for bio-printing three-dimensional matrices.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A method of forming a lymphoid organoid, comprising:
(a) providing a first polymer precursor solution; and (b) depositing a second polymer precursor solution adjacent to and in contact with said first polymer precursor solution, thereby forming said lymphoid organoid.
2 . The method of claim 1 , wherein said first polymer precursor solution and said second polymer precursor solution each comprise a plurality of cells.
3 . The method of claim 2 , wherein cells of said first polymer precursor solution and said second polymer precursor solution are different.
4 . The method of claim 3 , wherein said first polymer precursor solution comprises B cells.
5 . The method of claim 3 , wherein said second polymer precursor solution comprises T cells.
6 . The method of claim 2 , wherein said plurality of cells comprise human cells.
7 . The method of claim 2 , wherein said plurality of cells comprise activated cells.
8 . The method of claim 1 , wherein said first polymer precursor solution or said second polymer precursor solution comprises one or more support or accessory cells.
9 . The method of claim 8 , wherein said first polymer precursor solution or said second polymer precursor solution comprises one or more antigen presenting cells.
10 . The method of claim 1 , wherein said first polymer precursor solution or said second polymer precursor solution comprises collagen.
11 . The method of claim 1 , wherein said first polymer precursor solution or said second polymer precursor solution has a cell density at least about 10 5 cells/milliliter.
12 . The method of claim 1 , further comprising curing said first polymer precursor solution prior to (b).
13 . The method of claim 12 , further comprising using heat to cure said first polymer precursor or said second polymer precursor.
14 . The method of claim 1 , wherein said lymphoid organoid comprises at least one tear drop shape.
15 . The method of claim 1 , further comprising, after (b), introducing one or more cells to said lymphoid organoid.
16 . The method of claim 1 , further comprising, after (b), stimulating said lymphoid organoid to form one or more immunological proteins.
17 . The method of claim 1 , wherein said lymphoid organoid is configured to facilitate cellular interactions.
18 . The method of claim 1 , wherein said lymphoid organoid has a dimension of at most about 500 micrometers.
19 . The method of claim 1 , wherein at most about 500 microliters of said first polymer precursor solution or said second polymer precursor solution is deposited in (a) or (b).
20 . The method of claim 19 , wherein at most about 5 microliters of said first polymer precursor solution or said second polymer precursor solution is deposited in (a) or (b).
21 . The method of claim 1 , further comprising repeating (a) and (b) for a plurality of lymphoid organoids.
22 . The method of claim 1 , wherein (a) comprises depositing said first polymer precursor solution adjacent to a support.
23 . The method of claim 22 , wherein said support is a part of a well.Join the waitlist — get patent alerts
Track US2022195394A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.